ArticleOptical and quantum electronics2021
Nanostructured ZnO and ZnO: Pd with MXene overlayer SPR biosensors.
Article in Optical and quantum electronics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MXene-Based Optical Fiber Sensors for Chemical and Biosensing: Review and Perspectives.Analytical chemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of biosensors based on various novel techniques has become highly significant in the context of the outburst of a pandemic like COVID 19. The present work reports the theoretical modeling of two surface plasmon resonance (SPR) based biosensing probe configurations on optical fiber employing Metal/ZnO/MXene and Metal/ZnO: Pd/MXene. Maximum sensitivities of 19,400 nm/RIU and 8350 nm/RIU are calculated with Metal/ZnO/MXene and Metal/ZnO: Pd/MXene, respectively. The sensors are suitable for analytes with refractive index values ranging from 1.354 to 1.422. The refractive index of mucus and serum being in this range, the proposed biosensor, can be a potential tool for COVID-19 detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.